Retraction Note to: Mol Neurobiol (2015) 52:270–276

DOI 10.1007/s12035-014-8872-9

This article has been retracted at the request of the Editor-in-Chief and the Publisher per the Committee on Publication Ethics guidelines. There is strong reason to believe that the peer review process was compromised and the authors have plagiarized parts from the following articles:

Xiangshan Yang, Shunzeng Lv, Yuting Liu, Daotang Li, Ranran Shi, Zhenyu Tang, Jianzhen Fan, Zhongfa Xu, The Clinical Utility of Matrix Metalloproteinase 9 in Evaluating Pathological Grade and Prognosis of Glioma Patients: A Meta-Analysis, Mol Neurobiol (2015) 52: 38. doi:10.1007/s12035-014-8850-2; Received: 20 July 2014.

Shunzeng Lv, Congxin Dai, Yuting Liu, Ranran Shi, Zhenyu Tang, Mingzhi Han, Ruixiang Bian, Bowen Sun, Renzhi Wang, The Impact of Survivin on Prognosis and Clinicopathology of Glioma Paents: A Systematic Meta-Analysis, Mol Neurobiol (2015) 51: 1462. doi:10.1007/s12035-014-8823-5; Received: 26 June 2014.

In addition, the article shows similarities with the following article which was submitted within a close timeframe:

Shunzeng Lv, Bowen Sun, Xiao Zhong, Congxin Dai, Weiping Wang, Xiaochen Ma, Huishu Song, Ranran Shi, Renzhi Wang, The Clinical Implications of Chemokine Receptor CXCR4 in Grade and Prognosis of Glioma Patients: A Meta-Analysis, Mol Neurobiol (2015) 52: 555. doi:10.1007/s12035-014-8894-3; Received: 20 August 2014

The article “The Clinical Implications of Transforming Growth Factor Beta in Pathological Grade and Prognosis of Glioma Patients: A Meta-Analysis” was received: 6 August 2014.